Vancomycin appeared to top placebo for lowering Clostridioides difficile infection (CDI) recurrence rates in patients taking ...

Fecal microbiota transplantation (FMT) could be considered as first-line therapy for primary Clostridioides difficile infection (CDI).

The bacterium Clostridioides difficle, or C. diff, is an urgent antibiotic resistance threat, causing half a million illnesses in the United States each year and nearly 30,000 deaths, according to the ...

TOPLINE: Signs of inflammatory bowel disease (IBD) activity, shorter duration of IBD, and previous corticosteroid use and hospitalisation were associated with Clostridioides difficile infection in ...

Recent estimates suggest C. difficile approaches 500,000 infections annually in the U.S. and is associated with approximately 20,000 deaths annually. (Guh, 2020, New England Journal of Medicine).

Hello Health Rounds Readers! Today we report on a promising animal study of a mRNA vaccine that could one day prevent or treat infection with the dangerous, often hospital-acquired C. difficile ...

If it's severe, your doctor might recommend stopping antibiotics until the diarrhea improves. C. diff diarrhea can take longer to clear up, and it may come back after you treat it. [4] ...

For example, some C. diff cells have flagella, long wiggly appendages that help them move around, while others don’t. This makes choosing a target for a vaccine tricky.

The superbug Clostridioides difficile, or C. diff, can cause dangerous gut infections. There are limited options for treating it, and patients often experience reinfection, which can be deadly.

The superbug Clostridioides difficile, or C. diff, can cause dangerous gut infections. There are limited options for treating it, and patients often experience reinfection, which can be deadly.